• Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic 

  Tombak, A; Tanrikulu, FP; Durusoy, SS; Dincyurek, HD; Kaya, E; Umit, EG; Yavasoglu, I; Mehtap, O; Deveci, B; Ozcan, MA; Terzi, H; Okay, M; Sayinalp, N; Yilmaz, M; Okan, V; Kizikli, A; Ozcan, O; Cetin, G; Demircioglu, S; Aydogdu, I; Saydam, G; Davulcu, EA; Ilhan, G; Ucar, MA; Ozet, G; Akpinar, S; Turgut, B; Berber, I; Kurtoglu, E; Sonmez, M; Batur, DS; Yildirim, R; Ozkocamaz, V; Gunes, AK; Sahip, B; Ertop, S; Akay, OM; Basturk, A; Dogu, MH; Akdeniz, A; Unal, A; Seyhanli, A; Gurkan, E; Cekdemir, D; Ferhanoglu, B (2021)

  Objective: This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients. Materials and Methods: A total of 136 patients ...
• Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An 

  Efe, C; Dhanasekaran, R; Lammert, C; Ebik, B; Higuera-de la Tijera, F; Aloman, C; Caliskan, AR; Peralta, M; Gerussi, A; Massoumi, H; Catana, AM; Torgutalp, M; Purnak, T; Rigamonti, C; Aldana, AJG; Khakoo, N; Kacmaz, H; Nazal, L; Frager, S; Demir, N; Irak, K; Ellik, ZM; Balaban, Y; Atay, K; Eren, F; Cristoferi, L; Batibay, E; Urzua, A; Snijders, R; Kiyici, M; Akyildiz, M; Ekin, N; Carr, RM; Harputluoglu, M; Hatemi, I; Mendizabal, M; Silva, M; Idilman, R; Silveira, M; Drenth, JPH; Assis, DN; Bjornsson, E; Boyer, JL; Invernizzi, P; Levy, C; Schiano, TD; Ridruejo, E; Wahlin, S (2021)

  Background and Aims Data regarding outcome of COVID-19 in patients with autoimmune hepatitis (AIH) are lacking.
• Characteristics and outcomes of hospitalised older patients with chronic 

  Ozturk, S; Turgutalp, K; Arici, M; Gok, M; Islam, M; Altiparmak, MR; Aydin, Z; Doner, B; Eren, N; Sengul, E; Karadag, S; Ozler, TE; Dheir, H; Pembegul, I; Taymez, DG; Sahin, G; Bakirdogen, S; Dolarslan, ME; Soypacaci, Z; Hur, E; Kara, E; Basturk, T; Ogutmen, MB; Gorgulu, N; Sahin, I; Ayli, MD; Tuglular, ZS; Tokgoz, B; Tonbul, HZ; Yildiz, A; Sezer, S; Odabas, AR; Ates, K (2021)

  Objective Older adults with co-morbidities have been reported to be at higher risk for adverse outcomes of coronavirus disease 2019 (COVID-19). The characteristics of COVID-19 in older patients and its clinical outcomes ...
• Bi-allelic variants in SPATA5L1 lead to intellectual disability, 

  Richard, EM; Bakhtiari, S; Marsh, APL; Kaiyrzhanov, R; Wagner, M; Shetty, S; Pagnozzi, A; Nordlie, SM; Guida, BS; Cornejo, P; Magee, H; Liu, J; Norton, BY; Webster, RI; Worgan, L; Hakonarson, H; Li, JK; Guo, YR; Jain, M; Blesson, A; Rodan, LH; Abbott, MA; Comi, A; Cohen, JS; Alhaddad, B; Meitinger, T; Lenz, D; Ziegler, A; Kotzaeridou, U; Brunet, T; Chassevent, A; Smith-Hicks, C; Ekstein, J; Weiden, T; Hahn, A; Zharkinbekova, N; Turnpenny, P; Tucci, A; Yelton, M; Horvath, R; Gungor, S; Hiz, S; Oktay, Y; Lochmuller, H; Zollino, M; ManuelaMorleo; Marangi, G; Nigro, V; Torella, A; Pinelli, M; Amenta, S; Husain, RA; Grossmann, B; Rapp, M; Steen, C; Marquardt, I; Grimmel, M; Grasshoff, U; Korenke, GC; Owczarek-Lipska, M; Neidhardt, J; Radio, FC; Mancini, C; Sepulveda, DJC; Mc Walter, K; Begtrup, A; Crunk, A; Sacoto, MJG; Person, R; Schnur, RE; Mancardi, MM; Kreuder, F; Striano, P; Zara, F; Chung, WK; Marks, WA; van Eyk, CL; Webber, DL; Corbett, MA; Harper, K; Berry, JG; Mac Lennan, AH; Gecz, J; Tartaglia, M; Salpietro, V; Christodoulou, J; Kaslin, J; Padilla-Lopez, S; Bilguvar, K; Munchau, A; Ahmed, ZM; Hufnagel, RB; Fahey, MC; Maroofian, R; Houlden, H; Sticht, H; Mane, SM (2021)

  Spermatogenesis-associated 5 like 1 (SPATA5L1) represents an orphan gene encoding a protein of unknown function. We report 28 bi-allelic variants in SPATA5L1 associated with sensorineural hearing loss in 47 individuals ...
• Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine 

  Tanriover, MD; Doganay, HL; Akova, M; Guner, HR; Azap, A; Akhan, S; Kose, S; Erdinc, FS; Akalin, EH; Tabak, OF; Pullukcu, H; Batum, O; Yavuz, SS; Turhan, O; Yildirmak, MT; Koksal, I; Tasova, Y; Korten, V; Yilmaz, G; Celen, MK; Altin, S; Celik, I; Bayindir, Y; Karaoglan, I; Yilmaz, A; Ozkul, A; Gur, H; Unal, S (2021)

  Background CoronaVac, an inactivated whole-virion SARS-CoV-2 vaccine, has been shown to be well tolerated with a good safety profile in individuals aged 18 years and older in phase 1/2 trials, and provided a good humoral ...
• Effectiveness and treatment retention of TNF inhibitors when used as 

  Lindstrom, U; Di Giuseppe, D; Delcoigne, B; Glintborg, B; Moller, B; Ciurea, A; Pombo-Suarez, M; Sanchez-Piedra, C; Eklund, K; Relas, H; Gudbjornsson, B; Love, TJ; Jones, GT; Codreanu, C; Ionescu, R; Nekvindova, L; Zavada, J; Atas, N; Yolbas, S; Fagerli, KM; Michelsen, B; Rotar, Z; Tomsic, M; Iannone, F; Santos, MJ; Avila-Ribeiro, P; Ornbjerg, LM; Ostergaard, M; Jacobsson, LTH; Askling, J; Nissen, MJ (2021)

  Background Comedication with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) during treatment with tumour necrosis factor inhibitors (TNFi) is extensively used in psoriatic arthritis (PsA), although ...
• COVID-19 clinical course and blood groups: Turkish population-based 

  Dal, MS; Ata, N; Altuntas, F; Basci, S; Yigenoglu, TN; Korkmaz, S; Namdaroglu, S; Basturk, A; HacibekIroglu, T; Dogu, MH; Berber, I; Dal, K; Erkurt, MA; Turgut, B; Caglayan, M; Imrat, E; Celik, O; Ulgu, MM; Birinci, S (2021)

  Background/aim: SARS-CoV-2 enters the cell through the binding of the S glycoprotein on the surface of the virus to the angiotensin-converting enzyme 2 (ACE-2) in the host cells and also SARS-CoV S protein binding to ACE-2 ...
• Effects of immunosuppressive drugs on COVID-19 severity in patients with 

  Efe, C; Lammert, C; Tascilar, K; Dhanasekaran, R; Ebik, B; Higuera-de la Tijera, F; Caliskan, AR; Peralta, M; Gerussi, A; Massoumi, H; Catana, AM; Purnak, T; Rigamonti, C; Aldana, AJG; Khakoo, N; Nazal, L; Frager, S; Demir, N; Irak, K; Melekoglu-Ellik, Z; Kacmaz, H; Balaban, Y; Atay, K; Eren, F; Alvares-da-Silva, MR; Cristoferi, L; Urzua, A; Eskazan, T; Magro, B; Snijders, R; Barutcu, S; Lytvyak, E; Zazueta, GM; Demirezer-Bolat, A; Aydin, M; Heurgue-Berlot, A; De Martin, E; Ekin, N; Yildirim, S; Yavuz, A; Biyik, M; Narro, GC; Kiyici, M; Akyildiz, M; Kahramanoglu-Aksoy, E; Vincent, M; Carr, RM; Gunsar, F; Reyes, EC; Harputluoglu, M; Aloman, C; Gatselis, NK; Ustundag, Y; Brahm, J; Vargas, NCE; Guzelbulut, F; Garcia, SR; Aguirre, J; Anders, M; Ratusnu, N; Hatemi, I; Mendizabal, M; Floreani, A; Fagiuoli, S; Silva, M; Idilman, R; Satapathy, SK; Silveira, M; Drenth, JPH; Dalekos, GN; Assis, DN; Bjornsson, E; Boyer, JL; Yoshida, EM; Invernizzi, P; Levy, C; Montano-Loza, AJ; Schiano, TD; Ridruejo, E; Wahlin, S (2022)

  Background We investigated associations between baseline use of immunosuppressive drugs and severity of Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis (AIH). Patients and methods Data of AIH patients with ...
• Higher rate of COVID-19 mortality in patients with type 1 than type 2 

  Demirci, I; Haymana, C; Tasci, I; Satman, I; Atmaca, A; Sahin, M; Ata, N; Unluturk, U; Cakal, E; Dagdelen, S; Sahin, I; Celik, O; Ertugrul, D; Demir, T; Emral, R; Caglayan, M; Salman, S; Birinci, S; Sonmez, A (2022)

  Introduction: COVID-19 disease has a worse prognosis in patients with diabetes, but comparative data about the course of COVID-19 in patients with type 1 (T1DM) and type 2 diabetes (T2DM) are lacking. The purpose of this ...
• Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients 

  Bozdag, SC; Seval, GC; Hindilerden, IY; Hindilerden, F; Andic, N; Baydar, M; Kaynar, LA; Toprak, SK; Goksoy, HS; Aydin, BB; Demirci, U; Can, F; Ozkocaman, V; Gunduz, E; Guven, ZT; Ozkurt, ZN; Demircioglu, S; Beksac, M; Ince, I; Yilmaz, U; Kucukdiler, HE; Abishov, E; Yavuz, B; Atas, U; Mutlu, YG; Bas, V; Ozkalemkas, F; Teke, HU; Gursoy, V; Celik, S; Ciftciler, R; Yagci, M; Topcuoglu, P; Ceneli, O; Abbasov, H; Selim, C; Ar, MC; Yucel, OK; Sadri, S; Albayrak, C; Demir, AM; Guler, N; Keklik, M; Terzi, H; Dogan, A; Yegin, ZA; Yuksel, MK; Yavasoglu, I; Bekoz, HS; Aksu, T; Maral, S; Erol, V; Kaynar, L; Ilhan, O; Bolaman, AZ; Sevindik, OG; Akyay, A; Ozcan, M; Gurman, G; Cangul, SU; Yavuz, Y; Kucukkaya, RD; Ozsan, GH (2022)

  Objective: Patients with solid malignancies are more vulnerable to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection than the healthy population. The outcome of SARS-CoV-2 infection in highly ...
• Thalassemia-free and graft-versus-host-free survival: outcomes of 

  Yesilipek, MA; Uygun, V; Kupesiz, A; Karasu, G; Ozturk, G; Ertem, M; Sasmaz, I; Daloglu, H; Guler, E; Hazar, V; Fisgin, T; Sezgin, G; Kansoy, S; Kuskonmaz, B; Akinci, B; Ozbek, N; Ince, EU; Ozturkmen, S; Kupesiz, FT; Yalcin, K; Anak, S; Bozkurt, C; Karakukcu, M; Kupeli, S; Albayrak, D; Oniz, H; Aksoylar, S; Okur, FV; Albayrak, C; Yenigurbuz, FD; Bozkaya, IO; Ileri, T; Gursel, O; Karagun, BS; Kintrup, GT; Celen, S; Elli, M; Aksoy, BA; Yilmaz, E; Tanyeli, A; Akyol, ST; Sivi, ZO; Ozek, G; Uckan, D; Kartal, I; Atay, D; Akyay, A; Bilir, OA; Cakmakl, HF; Kurekci, E; Malbora, B; Akbayram, S; Demir, HA; Kilic, SC; Gunes, AM; Zengin, E; Ozmen, S; Antmen, AB (2022)

  We report the national data on the outcomes of hematopoietic stem cell transplantation (HSCT) for thalassemia major (TM) patients in Turkey on behalf of the Turkish Pediatric Stem Cell Transplantation Group. We retrospectively ...
• The success of the Cystic Fibrosis Registry of Turkey for improvement of 

  Asfuroglu, P; Eyuboglu, TS; Aslan, AT; Gursoy, TR; Emiralioglu, N; Yalcin, E; Kiper, N; Sen, V; Sen, HS; Altintas, DU; Ozcan, D; Kilinc, AA; Cokugras, H; Baskan, AK; Yazan, H; Erenberk, U; Dogan, G; Unal, G; Yilmaz, AI; Keskin, O; Arik, E; Kucukosmanoglu, E; Irmak, I; Damadoglu, E; Ozturk, GK; Gulen, F; Basaran, AE; Bingol, A; Cekic, S; Sapan, N; Kilic, G; Harmanci, K; Kose, M; Ozdemir, A; Tugcu, GD; Polat, SE; Hangul, M; Ozcan, G; Aydin, ZGG; Yuksel, H; Topal, E; Ozdogan, S; Caltepe, G; Suleyman, A; Can, D; Ekren, PK; Bal, CM; Kilic, M; Cinel, G; Cobanoglu, N; Pekcan, S; Cakir, E; Ozcelik, U; Dogru, D (2022)

  Background Cystic fibrosis (CF) registries play an essential role in improving disease outcomes of people with CF. This study aimed to evaluate the association of newly established CF registry system in Turkey on follow-up, ...
• Frequency of Direct Oral Anticoagulants Usage in Acute Pulmonary 

  Tanriverdi, E; Tutar, N; Senturk, A; Bahadir, A; Aksel, N; Yetkin, NA; Karadeniz, G; Cetin, N; Tabaru, A; Yildirim, BZ; Sen, HS; Ozcelik, N; Ozsari, E; Uzer, F; Cicek, T; Esendagli, D; Hocanli, I; Kocak, ND; Tapan, U; Kurt, B; Arinc, S; Kavas, M; Sahin, F; Ergun, D; Ucar, EY; Kilic, T; Gulmez, I; Emre, JC; Dogan, D; Ozdemir, F; Duger, M; Alzafer, S; Yarar, E; Unat, DS; Salik, B (2022)

  Background: Direct oral anticoagulants (DOACs) have been used in acute pulmonary thromboembolism as an alternative to warfarin due to drug interactions, narrow therapeutic range, and necessary close International Normalized ...
• Risk factors and outcomes associated with recurrent autoimmune hepatitis 

  Montano-Loza, AJ; Ronca, V; Ebadi, M; Hansen, BE; Hirschfield, G; Elwir, S; Alsaed, M; Milkiewicz, P; Janik, MK; Marschall, HU; Burza, MA; Efe, C; Caliskan, AR; Harputluoglu, M; Kabacam, G; Terrabuio, D; Onofrio, FD; Selzner, N; Bonder, A; Pares, A; Llovet, L; Akyildiz, M; Arikan, C; Manns, MP; Taubert, R; Weber, AL; Schiano, TD; Haydel, B; Czubkowski, P; Socha, P; Oldak, N; Akamatsu, N; Tanaka, A; Levy, C; Martin, EF; Goel, A; Sedki, M; Jankowska, I; Ikegami, T; Rodriguez, M; Sterneck, M; Weiler-Normann, C; Schramm, C; Donato, MF; Lohse, A; Andrade, RJ; Patwardhan, VR; van Hoek, B; Biewenga, M; Kremer, AE; Ueda, Y; Deneau, M; Pedersen, M; Mayo, MJ; Floreani, A; Burra, P; Secchi, MF; Beretta-Piccoli, BT; Sciveres, M; Maggiore, G; Jafri, SM; Debray, D; Girard, M; Lacaille, F; Lytvyak, E; Mason, AL; Heneghan, M; Oo, YH (2022)

  Background & Aims: Autoimmune hepatitis can recur after liver transplantation (LT), though the impact of recurrence on patient and graft survival has not been well characterized. We evaluated a large, international, ...
• Coexistence of Ovarian Granulose Cell Tumor, Congenital Adrenal 

  Akbulut, S; Ceylan, SD; Tuncali, T; Sogutcu, N (2021)

  Purpose Congenital adrenal hyperplasia (CAH) is rare autosomal recessive disease. CAH due to 21-hydroxylase deficiency accounts for 95% of cases. We aimed to share the first case of coexistence of simple virilizing-type ...
• COVID-19 in hematopoietic cell transplant recipients 

  Altuntas, F; Ata, N; Yigenoglu, TN; Basci, S; Dal, MS; Korkmaz, S; Namdaroglu, S; Basturk, A; Hacibekiroglu, T; Dogu, MH; Berber, I; Dal, K; Erkurt, MA; Turgut, B; Ulgu, MM; Celik, O; Akunal, A; Birinci, S (2021)

  In this study, we aim to report the outcome of COVID-19 in hematopoietic cell transplant (HCT) recipients. HCT recipients (n = 32) with hematological disease and hospitalized for COVID-19 were included in the study. A ...
• Characteristics of primary glomerular diseases patients with hematuria 

  Sumnu, A; Turkmen, K; Cebeci, E; Turkmen, A; Eren, N; Seyahi, N; Oruc, A; Dede, F; Derici, U; Basturk, T; Sahin, G; Sipahioglu, M; Sahin, GM; Tatar, E; Dursun, B; Sipahi, S; Yilmaz, M; Suleymanlar, G; Ulu, S; Gungor, O; Kutlay, S; Bahcebasi, ZB; Sahin, I; Kurultak, I; Sevinc, C; Yilmaz, Z; Kazancioglu, RT; Cavdar, C; Candan, F; Aydin, Z; Oygar, D; Gul, B; Altun, B; Paydas, S; Uzun, S; Istemihan, Z; Ergul, M; Dincer, MT; Gullulu, M; Piskinpasa, S; Akcay, OF; Unsal, A; Koyuncu, S; Gok, M; Ozturk, S (2021)

  Purpose Hematuria is one of the most common laboratory findings in nephrology practice. To date, there is no enough data regarding the clinical and histopathologic characteristics of primary glomerular disease (PGD) patients ...
• Oxygen, pH, Lactate, and Metabolism-How Old Knowledge and New Insights 

  Haller, HL; Sander, F; Popp, D; Rapp, M; Hartmann, B; Demircan, M; Nischwitz, SP; Kamolz, LP (2021)

  Over time, we have come to recognize a very complex network of physiological changes enabling wound healing. An immunological process enables the body to distinguish damaged cells and begin a cleaning mechanism by separating ...
• The combination of N-acetylcysteine and cyclosporin A reduces 

  Tektemur, NK; Guzel, EE; Gul, M; Tektemur, A; Yildirim, SO; Balgetir, MK; Kocamuftuoglu, GO; Yalcin, T; Ozan, IE (2021)

  Acetaminophen (APAP)-induced hepatotoxicity is the most common cause of acute liver failure in worldwide. N-acetyl cysteine (NAC) is used as the APAP antidote. Cyclosporin A (CsA) is suppressed mitochondrial damage by ...
• Essential oil chemical composition, antimicrobial, anticancer, and 

  Yuceturk, SC; Turkoglu, SA; Kockar, F; Kucukbay, FZ; Azaz, AD (2021)

  In this study, the chemical composition, antimicrobial, antioxidant, and anticancer effects of Thymus convolutus Klokov oil and its main compound camphor were investigated. The oil was isolated from T. convolutus using ...

View more